Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine + Bortezomib + Dexamethasone in Relapsed Multiple Myeloma
NCT01002248Phase 3Terminated
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Dec 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of perifosine in multiple myeloma (MM), sponsored by COSCIENS Biopharma Inc.. Started Dec 2009; status: terminated.
02
Drugs
perifosine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01002248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002248.